Default company panoramic image
Logo

Lucigen

Molecular point-of-care detection of infectious disease - as sensitive as central lab tests and as fast & inexpensive as rapid antigen tests

  • Stage $3M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Middleton, WI, USA
  • Currency USD
  • Founded January 1998
  • Employees 35
  • Website lucigen.com

Company Summary

Lucigen is a successful life sciences/research tools company in the molecular biology arena. We are highly-regarded for our cloning, phage display, protein engineering and enzyme discovery. Amongst our customers are leading companies such as Novartis, Pfizer and Life Technologies. Lucigen has been profitable and cash-flow positive since 2007. We are seeking to enter the clinical diagnostics space, leveraging our patented PyroScript(R) enzyme.

Team

  • Default avatar
    David Mead, Ph.D.
    CEO and Founder

  • Default avatar
    Jeff Williams, Ph.D.
    President

  • Default avatar
    Andy Shrago
    VP, Business Development

  • Default avatar
    Ralph Kauten
    Chairman of the Board

Advisors

  • Default avatar
    DeWitt, Ross & Stephens
    Lawyer
    Unconfirmed
    Default avatar
    Smith & Gesteland
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    100% Angel Funded
    Unconfirmed